Company profile: TcLand Expression
1.1 - Company Overview
Company description
- Provider of companion diagnostics development in Immune Mediated Disorders and biomarker development in Solid Organ Transplantation, supported by strong immunology expertise and preferred access to patient cohorts, searching and developing biomarkers for a wide range of grafts.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TcLand Expression
Radient Pharma
HQ: United States
Website
- Description: Provider of cancer diagnostic tests and proprietary cancer vaccine technology, offering Onko-Sure, an in vitro blood test to detect and monitor solid tumor cancers by measuring Fibrin and Fibrinogen Degradation Products, and Combination Immunogene Therapy (CIT), designed to enhance the immune system’s ability to destroy cancer cells by incorporating genes into tumor cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Radient Pharma company profile →
4D Lifetec
HQ: Switzerland
Website
- Description: Provider of molecular diagnostic screening and test systems, including DNA defect and repair-based screening programs, and non-invasive immuno-oncological blood tests for early cancer detection. Offers 4D Lifetest to detect stages I and II via DNA fragmentation using the DDS biomarker, and 4D Lifetest Lung Dx for early-stage lung cancer, reducing invasive procedures and guiding treatment paths.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4D Lifetec company profile →
Fluxion Biosciences
HQ: United States
Website
- Description: Provider of cellular analysis tools and drug discovery applications, built on a proprietary microfluidic platform enabling precise cellular manipulation, low-volume compound addition, environmental control, and software-based data acquisition. Offerings include BioFlux Systems, IonFlux Mercury Systems, CellRaft AIR System, CERO 3D Incubator & Bioreactor, CASY Cell Counter & Analyzer, and TIGR Tissue Grinder and Dissociator.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluxion Biosciences company profile →
Monogram Biosciences
HQ: United States
Website
- Description: Provider of innovative products to guide and improve treatment of infectious diseases, cancer, and other serious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Monogram Biosciences company profile →
Genetic Analysis
HQ: Norway
Website
- Description: Provider of DNA-based molecular diagnostics for gut microbiota-related diseases, leveraging GA-map array technology to rapidly profile patient gut microbiota and link to health conditions. Offers GA-map Dysbiosis Test Lx for IBS and IBD, GA-map COVID-19 fecal PCR test, clinical research services for microbiota analysis, and companion diagnostics co-development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genetic Analysis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TcLand Expression
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TcLand Expression
2.2 - Growth funds investing in similar companies to TcLand Expression
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TcLand Expression
4.2 - Public trading comparable groups for TcLand Expression
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →